NatureWise Biotech & Medicals Corporation (TPEX:4732)

Market Cap	944.75M
Revenue (ttm)	180.29M
Net Income (ttm)	-37.01M
Shares Out	47.00M
EPS (ttm)	-0.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,220
Average Volume	20,613
Open	20.10
Previous Close	20.10
Day's Range	19.70 - 20.20
52-Week Range	17.40 - 27.85
Beta	0.72
RSI	41.90
Earnings Date	Nov 14, 2025

About TPEX:4732

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 32
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4732

Financial Performance

In 2024, TPEX:4732's revenue was 224.32 million, an increase of 40.08% compared to the previous year's 160.14 million. Earnings were 897,000, a decrease of -91.14%.